Evidence map›Paper›PMID 29242398›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2018

Impact of

Jeremie Calais, Wolfgang P Fendler, Matthias Eiber, Jeannine Gartmann, Fang-I Chu, Nicholas G Nickols, Robert E Reiter, Matthew B Rettig, Leonard S Marks, Thomas E Ahlering and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Impact ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
    Trial
  5. Impact ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
    Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. [Diagnostics (Basel, Switzerland) · 2024
    Article
  18. Article
  19. Comparison of digital and analog [Scientific reports · 2024
    Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Jeremie CalaisAhmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California jcalais@mednet.ucla.edu.
Wolfgang P FendlerAhmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California.
Matthias EiberAhmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California.
Jeannine GartmannAhmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California.
Fang-I ChuDepartment of Radiation Oncology, UCLA Medical Center, Los Angeles, California.
Nicholas G NickolsDepartment of Radiation Oncology, UCLA Medical Center, Los Angeles, California.
Robert E ReiterDepartment of Urology, UCLA Medical Center, Los Angeles, California; and.
Matthew B RettigDepartment of Urology, UCLA Medical Center, Los Angeles, California; and.
Leonard S MarksDepartment of Urology, UCLA Medical Center, Los Angeles, California; and.
Thomas E AhleringDepartment of Urology, UC Irvine Health, Irvine, California.
Linda M HuynhDepartment of Urology, UC Irvine Health, Irvine, California.
Roger SlavikAhmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California.
Pawan GuptaAhmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California.
Andrew QuonAhmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California.
Martin S Allen-AuerbachAhmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California.
Johannes CzerninAhmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California.
Ken HerrmannAhmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, California.

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
UCLA SPORE IN PROSTATE CANCERP50CA092131 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FREEMAN, MICHAEL R · 2002 to 2023
$42.6M
UCLA SPORE in Brain CancerP50CA211015 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI David A. Nathanson · 2017 to 2026
$25.2M
NCI NIH HHS P30 CA016042NCI NIH HHS P50 CA211015
6 · The paper itself

Abstract

In this prospective survey of referring physicians, we investigated whether and how

Indexed as

OligopeptidesPositron Emission Tomography Computed TomographyAgedEdetic AcidGallium IsotopesGallium RadioisotopesHumansMaleProstatic NeoplasmsRecurrenceEdetic Acidgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesOligopeptides68Ga-PSMAbiochemical recurrenceimpact on implemented managementPET/CTprostate cancer

Identifiers

PMID29242398
PMCPMC5868499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.